Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment?

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 519-528

  Voß, Elke Verena ^a   Škuljec, Jelena ^a,b   Gudi, Viktoria ^a,b   Skripuletz, Thomas ^a   Pul, Refik ^a   Trebst, Corinna ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Cuprizone; Microglia; Phagocytosis; Remyelination

Indexed keywords

CELL SURFACE MARKER; CUPRIZONE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REMYELINIZATION; TISSUE REPAIR;

ANIMALS; CUPRIZONE; CYTOKINES; DEMYELINATING DISEASES; MALE; MICE; MICROGLIA; MYELIN SHEATH; PHAGOCYTOSIS; UP-REGULATION; WOUND HEALING;

EID: 81955164222     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.09.008     Document Type: Article

References (59)

1. Aberg N.D., Brywe K.G., Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 2006, 6:53-80.
2. Adams C.W., Poston R.N., Buk S.J. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J. Neurol. Sci. 1989, 92:291-306.
3. Armstrong R.C., Le T.Q., Flint N.C., Vana A.C., Zhou Y.X. Endogenous cell repair of chronic demyelination. J. Neuropathol. Exp. Neurol. 2006, 65:245-256.
4. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
5. Arnett H.A., Wang Y., Matsushima G.K., Suzuki K., Ting J.P. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J. Neurosci. 2003, 23:9824-9832.
6. Bakker D.A., Ludwin S.K. Blood-brain barrier permeability during cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J. Neurol. Sci. 1987, 78:125-137.
7. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458-468.
8. Barnett M.H., Henderson A.P., Prineas J.W. The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Mult. Scler. 2006, 12:121-132.
9. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
10. de Haas A.H., Boddeke H.W., Biber K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 2008, 56:888-894.
11. Ford A.L., Goodsall A.L., Hickey W.F., Sedgwick J.D. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 1995, 154:4309-4321.
12. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 2002, 3:705-714.
13. Franklin R.J., Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
14. Gay F.W. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen. Clin. Neurol. Neurosurg. 2006, 108:234-240.
15. Goldschmidt T., Antel J., Konig F.B., Bruck W., Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009, 72:1914-1921.
16. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
17. Gudi V., Moharregh-Khiabani D., Skripuletz T., Koutsoudaki P.N., Kotsiari A., Skuljec J., et al. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 2009, 1283:127-138.
18. Hakola H.P. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr. Scand. Suppl. 1972, 232:1-173.
19. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
20. Henderson A.P., Barnett M.H., Parratt J.D., Prineas J.W. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann. Neurol. 2009, 66:739-753.
21. Hickey W.F. The pathology of multiple sclerosis: a historical perspective. J. Neuroimmunol. 1999, 98:37-44.
22. Hsieh J., Aimone J.B., Kaspar B.K., Kuwabara T., Nakashima K., Gage F.H. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J. Cell Biol. 2004, 164:111-122.
23. Kaga Y., Shoemaker W.J., Furusho M., Bryant M., Rosenbluth J., Pfeiffer S.E., et al. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J. Neurosci. 2006, 26:12339-12350.
24. Kondo A., Nakano T., Suzuki K. Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res. 1987, 425:186-190.
25. Kotter M.R., Li W.W., Zhao C., Franklin R.J. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 2006, 26:328-332.
26. Kumar S., Biancotti J.C., Yamaguchi M., de Vellis J. Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem. Res. 2007, 32:783-797.
27. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., et al. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 2008, 34:105-114.
28. Liu Y., Hao W., Letiembre M., Walter S., Kulanga M., Neumann H., et al. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 2006, 26:12904-12913.
29. Magnus T., Chan A., Grauer O., Toyka K.V., Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 2001, 167:5004-5010.
30. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
31. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 2000, 20:5703-5708.
32. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 2001, 21:7046-7052.
33. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
34. McKinnon R.D., Matsui T., Dubois-Dalcq M., Aaronson S.A. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990, 5:603-614.
35. McMahon E.J., Suzuki K., Matsushima G.K. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J. Neuroimmunol. 2002, 130:32-45.
36. Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 2011, Jul 5 [Epub ahead of print].
37. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209-212.
38. Muir D.A., Compston D.A. Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J. Neurosci. Res. 1996, 44:1-11.
39. Nasu T., Tsukahara Y., Terayama K. A lipid metabolic disease - "membranous lipodystrophy" - an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol. Jpn 1973, 23:539-558.
40. Neumann H., Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J. Neuroimmunol. 2007, 184:92-99.
41. Neumann H., Kotter M.R., Franklin R.J. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295.
42. Oh L.Y., Denninger A., Colvin J.S., Vyas A., Tole S., Ornitz D.M., et al. Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation. J. Neurosci. 2003, 23:883-894.
43. Paloneva J., Autti T., Raininko R., Partanen J., Salonen O., Puranen M., et al. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology 2001, 56:1552-1558.
44. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
45. Patani R., Balaratnam M., Vora A., Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 2007, 33:277-287.
46. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172.
47. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, New York.
48. Perez-Martin M., Cifuentes M., Grondona J.M., Lopez-Avalos M.D., Gomez-Pinedo U., Garcia-Verdugo J.M., et al. IGF-I stimulates neurogenesis in the hypothalamus of adult rats. Eur. J. Neurosci. 2010, 31:1533-1548.
49. Perry V.H., Gordon S. Macrophages and the nervous system. Int. Rev. Cytol. 1991, 125:203-244.
50. Piccio L., Buonsanti C., Mariani M., Cella M., Gilfillan S., Cross A.H., et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2007, 37:1290-1301.
51. Prineas J.W., Graham J.S. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 1981, 10:149-158.
52. Prinz M., Mildner A. Microglia in the CNS: immigrants from another world. Glia 2011, 59:177-178.
53. Remington L.T., Babcock A.A., Zehntner S.P., Owens T. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 2007, 170:1713-1724.
54. Sedgwick J.D., Schwender S., Imrich H., Dorries R., Butcher G.W., ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7438-7442.
55. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., et al. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 2008, 172:1053-1061.
56. Skripuletz T., Bussmann J.H., Gudi V., Koutsoudaki P.N., Pul R., Moharregh-Khiabani D., et al. Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol. 2010, 20:301-312.
57. Sriram S., Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis. Neurology 1997, 48:464-470.
58. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201:647-657.
59. Takahashi K., Prinz M., Stagi M., Chechneva O., Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007, 4:e124.